GenMont Biotech Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - GenMont Biotech Inc

Watchlist Manager

Watchlist

Price: 16.7 TWD 0.91% Market Closed

Market Cap: NT$1.4B

	GenMont Biotech Inc TWSE:3164	TW
	United Overseas Bank Ltd SGX:U11	SG
T	Tandy Leather Factory Inc NASDAQ:TLF	US
P	Publicis Groupe SA OTC:PGPEF	FR
E	Experian PLC F:J2B	IE
	Bank of China Ltd HKEX:3988	CN
	Triple Flag Precious Metals Corp TSX:TFPM	CA
M	Matas A/S F:1MTA	DK
H	Hormel Foods Corp F:HO7	US
A	Apple Inc XMUN:APC	US
	Compagnie Immobiliere de Belgique F:R5L	BE
F	FSBM Holdings Bhd KLSE:FSBM	MY
S	Spire Inc F:LGR	US
	PostNL NV AEX:PNL	NL

Profitability Summary

GenMont Biotech Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

60%

Strong 3Y Average Gross Margin

63%

Declining Gross Margin

67% > 60%

Low Operating Margin

Low 3Y Average Operating Margin

10%

Declining Operating Margin

8% > 7%

Healthy Net Margin

18%

Sustainable 3Y Average Net Margin

13%

Net Margin is Increasing

14% > 18%

Exceptional Free Cash Flow Margin

22%

Strong 3Y Average Free Cash Flow Margin

15%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.